Health ❯ Healthcare

Drug Safety

Adverse Effects Side Effects Adverse Reactions Adverse Events Quality Control Efficacy Studies Regulatory Actions Drug Interactions Contamination Regulation Counterfeit Medications Regulatory Affairs Clinical Trials Regulations Pregnancy Risks Compounding Pharmacies Consumer Protection Patient Outcomes FDA Regulations Food Supply Safety Evaluation Methods Opioids Compounded Drugs Bleeding Risks Quality Assurance Recalls Inspection Processes Pharmaceuticals Clinical Studies Dosage Guidelines Risk Assessment Laboratory Compliance Clinical Outcomes Adverse Drug Reactions Inspections Risk Evaluation and Mitigation Strategy Prescription Medications Clinical Research Consumer Information Drug Efficacy Non-Steroidal Anti-Inflammatory Drugs Recall Classifications Risk Management Contaminated Drugs Safety Assessments Cough Syrups Acetaminophen Black Market Medications Compounded Medications Fentanilo Warnings and Precautions Therapeutic Justification Substance Abuse Monitoring Systems Tolerability Profiles Efficacy Concerns Efficacy Testing Counterfeit Drugs Contaminants GLP-1 Receptor Agonists Treatment Efficacy Pregnancy Abortion Pills FDA Warnings Drug Testing Counterfeit Medicines Pharmacovigilance

Aficamten Improves Symptoms and Exercise Capacity in Nonobstructive HCM

Cytokinetics plans a U.S. supplemental filing following results that raise the need for strict ejection‑fraction monitoring.

FDA Approves Lisraya as First Oral Treatment for Adult Dermatomyositis

Amylyx’s Avexitide Cuts Moderate‑to‑Severe Post‑Bariatric Hypoglycemia Events 55% in Phase 3

Sionna Halts SION-719 After Mid-Stage Cystic Fibrosis Trial Misses Key Biomarker

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

EMA Committee Recommends Revoking Tavneos Authorization

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

Abivax Drug Shows Breakthrough Ulcerative Colitis Results as Shares Plunge After Cancer Cases

FDA Approves Durvalumab Plus BCG for High‑Risk Non‑Muscle Invasive Bladder Cancer

FDA Clears First Biosimilars to Simponi and Simponi Aria: IMMGOLIS and IMMGOLIS INTRI

Imfinzi With Enfortumab Vedotin Improves Survival in Phase III Bladder Cancer Trial

FDA Clears Dupixent as First Biologic for Young Children With Chronic Spontaneous Urticaria

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

Autolus Reports Q4 Loss, Reaffirms 2026 Sales Outlook for AUCATZYL, and Starts AUTO8 Trial

FDA Approves Sotyktu for Active Psoriatic Arthritis as First TYK2 Inhibitor

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

FDA Delays Two Drugs in National Priority Voucher Program After Safety, Efficacy Flags